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Abstract 
Background: Interleukin-12 is an important cytokine in mediating cellular immune responses.
Results: Recombinant single-chain canine IL-12 was produced in a baculovirus-insect cell system with the aim of 
conducting further studies on modulation of immune responses in dogs. To optimize the production of recombinant 
canine IL-12, a classical baculovirus and a modified vector (chitinase A and v-cathepsin knockout) were used contain-
ing a native or an optimized insert of canine IL-12. The optimized IL-12 construct contained the GP64 signal peptide 
and was synthesized with optimized codons for expression in Trichoplusia ni cells. Dot-blot and Western blot analysis 
showed the highest production levels of recombinant IL-12 protein by the use of the modified baculovirus vec-
tor containing the optimized insert, at a multiplicity of infection of five and at 48 h after infection. The recombinant 
cytokine was successfully purified and showed a good degree of purity, integrity, folding, and yield, with very little 
endotoxin contamination. Recombinant canine IL-12 induced IFN-γ in canine lymphocytes, indicating that it was 
biologically active.
Conclusion: Therefore, this study describes an efficient method to produce adequate amounts of biologically active 
canine IL-12, useful for immunomodulation studies in dogs.
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Background
Interleukin-12 was originally described as natural killer 
cell stimulatory factor-NKSF for its ability to promote 
activation of NK cells [1]. This cytokine plays an impor-
tant role in inducing IFN-γ production by T and natural 
killer cells [1, 2], and in differentiation of Th1 CD4 ± T 
cells [3, 4]. Studies have shown that IL-12 has a potential 
therapeutic benefit in cancer [5, 6], infectious and inflam-
matory diseases, and as a vaccine adjuvant [7–9]. Thus, 
production of recombinant IL-12 has raised great interest 
in the scientific community.
Interleukin-12 (IL-12) is a 70  kDa heterodimeric 
cytokine composed of two disulfide-bonded subunits—
p40 and p35, [10–12]. The heterodimer (p70) is required 
for the biologic activity of IL-12 [13, 14]. In addition, only 
the posttranslational N glycosylated protein isoforms are 
biologically active [15]. Therefore, recombinant IL-12 
should be produced in eukaryotic cells to display func-
tional activity.
Okano et al. [16] cloned both subunits of canine IL-12 
and described their expression in mammalian cells. Later, 
canine IL-12, showing biological activity, was cloned 
and expressed as a single chain protein (rsccaIL-12) in 
the green monkey cell line COS-7 cells. rsccaIL-12 was 
able to induce IFN-γ mRNA expression in peripheral 
blood mononuclear cells (PBMC) from healthy and vis-
ceral leishmaniasis sick dogs [17]. However, the produc-
tion of tens of milligrams of recombinant proteins in 
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mammalian cells, necessary for pre-clinical trials in dogs, 
would be costly and laborious.
A feasible alternative for producing adequate 
amounts of the recombinant protein for pre-clinical 
trials is the baculovirus-insect cell system, which is 
being used extensively to express heterologous genes 
in insect cells cultures or insect larvae [18]. This sys-
tem allows for production of high levels of recombi-
nant proteins with posttranslational modifications, 
including N-glycosylation. Recombinant IL-12 subu-
nits, p35 and p40, of bovine [19] and equine [20] have 
been produced in insect cells, resulting in a bioactive 
IL-12 p70 heterodimer. Furthermore, Poot et  al. [21] 
have produced canine IL-12 in baculovirus-insect cell 
system using classical recombinant baculovirus and 
adherent insect cell cultures. However, this report 
lacks detailed information regarding production and 
yield of canine IL-12.
This study was conducted to determine appropri-
ate conditions to produce moderate amounts of canine 
IL-12 to assess in a near future the feasibility of induc-
ing Th1 immune responses in dogs, which would be use-
ful in developing vaccines and treating diseases caused 
by intracellular pathogens, allergic diseases, and cancers. 
Herein, to determine appropriate conditions to produce 
IL-12 canine in tens of milligrams, several factors were 
evaluated to optimize the production of recombinant 
canine IL-12 in the baculovirus-insect cell system, as fol-
lows, native IL-12 versus the codon optimized IL-12 con-
struct (both as a single-chain protein), the classical and 
a modified baculovirus vector, multiplicity of infection 
and time of infection. In addition, it is described a simple 
and an effective method to semi-quantitatively evaluate 
expression of secreted recombinant proteins in the bacu-
lovírus insect cell system (a dot-blot assay).
Methods
Insect cell lines and culture
Spodoptera frugiperda and Trichoplusia ni insect cell 
lines, Sf-9 and BTI-TN-5B1-4 (also called High-five), 
respectively, (Invitrogen, Carlsbad, USA) were used. 
Sf-9 cells were maintained in TNM-FH medium (Sigma 
Aldrich, St. Louis, USA) containing 10  % fetal bovine 
serum (FBS, Invitrogen), 0.1  % Pluronic F-68 solu-
tion (Sigma Aldrich), and 10  µg/mL gentamycin sul-
fate (Sigma Aldrich) (complete TMN-FH medium). 
High-five cells were cultured in Express-five serum-free 
medium (SFM) (Invitrogen) supplemented with 16  mM 
of l-glutamine (Invitrogen), and 10  µg/mL gentamycin 
(complete Express-five SFM medium). Cell cultures were 
carried out at 27 °C either as a monolayer or in suspen-
sion in shaker flasks, according to the manufacturer’s 
instructions.
Interleukin‑12 constructs
Two DNA constructs encoding canine IL-12 single-chain 
protein (sccaIL-12 and sccaIL-12opt, and Fig.  1) were 
cloned into the pFastBac1 plasmid (Invitrogen). The 
sccaIL-12 construct was originally cloned from native 
canine mRNA into the pcDNA3.1 plasmid [17] while 
sccaIL-12opt was synthesized with optimized codons 
for expression in T. ni by Geneart GmBH (Regensburg, 
Germany). The recombinant proteins encoded by the 
constructs sccaIL-12 and sccaIL-12opt were named rsc-
caIL-12S and rsccaIL-12L, corresponding to the length 
(short or long) of the polypeptide spacer between the p40 
and p35 chains, respectively. The successful introduction 
of inserts into the plasmid pFastBac1, generating the fol-
lowing constructs pFastBac1-sccaIL-12 and pFastBac1-
sccaIL12opt, was determined by DNA sequencing.
Fig. 1 Schematic diagram of DNA constructs encoding canine IL-12 single-chain protein. The construct with canine native DNA is composed in 
tandem by nucleotide sequences encoding: signal peptide of p40, p40 mature protein, spacer, p35 mature protein and His-tag (a); the construct 
with DNA optimized for Trichoplusia ni translation is composed in tandem by nucleotide sequences encoding: GP64 signal peptide of AcMNPV, p40 
mature protein, a spacer, p35 mature protein, spacer and His-tag (b)
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Generation of baculovirus encoding canine IL‑12
The inserts sccaIL-12 and sccaIL-12opt were trans-
posed from the pFastBac1 plasmid constructs to: (a) 
Autographa californica multiple nuclear polyhedrosis 
virus (AcMNPV) bacmid [22] (bacmid named AcBac, 
Bac-to-Bac system, Invitrogen, cat. 10360-014) and (b) 
a chitinase and v-cathepsin knockout bacmid (bacmid 
called AcBacΔCC, previously described by Kaba and 
collaborators) [23], using DH10Bac and DH10BacΔCC 
Escherichia coli strains, respectively. Recombinant 
AcBac-sccaIL-12, AcBac-sccaIL-12opt, AcBacΔCC-
sccaIL-12 and AcBacΔCC-sccaIL-12opt baculovirus 
constructs were obtained by transfecting Sf-9 cells with 
the corresponding bacmids using a Lipofectamine rea-
gent, following the manufacturer’s instructions (Invitro-
gen). Baculovirus constructs with the insert from empty 
pFastBac1 plasmid (Invitrogen) were used as negative 
controls (AcBac-pFast-cont and AcBacΔCC-pFast-cont). 
These controls were obtainedthe cell-free SN were stored 
by transposing the DNA segment between Tn7R and 
Tn7L from the pFastBac1 plasmid into either the AcBac 
or AcBacΔCC bacmid and then transfecting Sf-9 cells. 
Six days after transfection, Sf-9 cell culture suspensions 
were spun down at 500×g for 5  min and baculovírus-
containing SN were stored protected from light at 4  °C. 
To obtain high-titer viral stocks, log phase growing Sf-9 
cells (2 × 106/mL) cultured in suspension were infected 
at a multiplicity of infection (MOI) of 0.1, either for 72 h 
or until cell viability decreased to approximately 75  %, 
and then the cell supernatants (SN) were collected as 
described above. Baculovirus stocks were titrated using 
the end-point dilution assay [24].
Optimization of recombinant canine IL‑12 expression 
by insect cells
High-five cells (1  ×  106/well) cultured as monolayers 
in serum free medium in 6-well titration plates were 
infected with the recombinant baculovirus constructs 
(AcBac-sccaIL-12, AcBac-sccaIL-12opt, AcBacΔCC-
sccaIL-12, or AcBacΔCC-sccaIL-12opt) at MOI of 2, 5 
or 10. To assess secreted recombinant protein, the cell 
culture SN were collected at 24, 48 and 72 h post infec-
tion, floating cells were spun down at 500×g for 5  min, 
and the cell-free SN were stored at −20 °C until use. 
Recombinant canine IL-12 in the cell culture SN was 
evaluated by dot-blot assay, using mouse anti-histidine 
C-terminal antibodies (mouse anti-His-C Ab, Invitrogen) 
as described below.
Dot‑blot and Western blot analysis
For dot-blot assays, nitrocellulose membranes placed in 
a blotter device (BioRad, Hercules, United States) were 
directly coated with proteins from cell culture SN at 150 
µL/well. The membranes were blocked with tris-buffered 
saline, pH 7.6, containing 5 % powdered non-fat milk and 
0.05  % Tween 20 and developed with mouse anti-His-
C Ab (Invitrogen) diluted 1:5.000, goat anti-mouse IgG 
alkaline phosphatase-conjugate diluted 1:500 (Sigma-
Aldrich), and alkaline phosphatase substrate (5-bromo-
4-chloro-3-indolyl-phosphate and nitro blue tetrazolium, 
Sigma Aldrich). For Western blot analysis, samples of SN 
or cell lysate from similar volumes of cultures of High-
five cells infected with AcBac-pFast-cont, AcBacΔCC-
pFast-cont, AcBac-sccaIL-12, AcBacΔCC-sccaIL-12, 
AcBac-sccaIL-12opt or AcBacΔCC-sccaIL-12opt baculo-
virus contructs at a MOI 5 for 48  h were fractioned by 
polyacrylamide gel electrophoresis with dodecyl sodium 
sulfate (SDS–PAGE) and then transferred to nitrocellu-
lose membranes (BioRad). Detection of his-tagged pro-
tein was performed as described in the dot-blot assay.
Production of recombinant canine IL‑12 by High‑five cells
Production of recombinant canine IL-12 in High-five 
cells was carried out in 50 mL suspension cultures using 
complete Express-five-SFM. For this, exponentially grow-
ing cells were adjusted to 2 × 106/mL and then infected 
with AcBac∆CC-caIL-12opt at MOI 5. After 48  h of 
infection, cell suspension was centrifuged at 3.000×g for 
15 min, cell-free SN was spun down at 30.000×g for 1 h 
to remove the virus particles and, the resulting SN was 
stored at −70  °C until use. The virus-free SN was dia-
lyzed twice against 0.15  M phosphate-buffered saline, 
pH 7.8 (PBS) and once against binding buffer (20  mM 
Na2HPO4, 500  mM NaCl, 20  mM imidazole, pH 7.8), 
and then applied onto Histrap HP columns (GE Health-
care, Uppsala, Sweden) attached to an AKTA Purifier 
chromatography system (GE Healthcare). The column 
was washed with binding buffer and eluted using an 
imidazole linear gradient from 20 to 500 mM in 20 mM 
Na2HPO4, 500  mM NaCl, pH 7.8, buffer, following the 
manufacturer’s recommendations. The purified protein 
(rsccaIL-12L) was buffer exchanged to PBS using a Hitrap 
desalting column (GE Healthcare) and stored at −70 °C 
until use. Protein samples were assessed by SDS–PAGE 
using 12 % polyacrylamide gels and previously described 
Western blotting assay. A molecular weight calibration 
curve was prepared and molecular weight sizes of pro-
tein bands were estimated using GraphPad Prism v.5.0 
software (GraphPad Prism Inc., San Diego, CA). In addi-
tion, the protein and endotoxin concentrations were 
determined using Micro BCA protein assay kit (Thermo 
Scientific, Rockford, USA, cat. 23235) and Limulus ame-
bocyte lysate method (Lonza, Walkersville, USA, cat. 
50-647U), respectively.
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Circular dichroism measurements
Circular dichroism spectra of rsccaIL-12L were obtained 
at 0.7 mg/mL protein concentration. Far-UV spectra were 
measured from 190 to 260 nm, averaged over three scans 
at a speed of 50 nm/min, and collected in 1 nm steps. The 
buffer baselines were subtracted from their respective 
sample spectra. These measurements were carried using 
a Jasco J-815 spectropolarimeter (Jasco Corp., Tokyo, 
Japan) with a 0.2 cm path-length quartz cuvette.
Fluorescence spectroscopy measurements
Tryptophan fluorescence emission spectra were obtained 
and recorded by setting the excitation wavelength at 
280  nm and the emission spectrum was recorded from 
295 to 415 nm using a Jasco FP-6500 spectrofluorimeter 
(Jasco Corp.).
Assessment of interferon gamma (IFN‑γ) production 
by peripheral blood mononuclear cells (PBMC) stimulated 
with purified recombinant canine IL‑12
Peripheral blood samples collected from six healthy adult 
mongrel dogs (three males and three females) were used. 
These animals were donated while still puppies to Gon-
çalo Moniz Research Center kennel by their owners. 
Thereafter the animals were housed at Gonçalo Moniz 
Research Center kennel. The experiments were per-
formed in accordance with the guidelines of the Oswaldo 
Cruz Foundation for laboratory animal use and approved 
by Gonçalo Moniz Research Center Ethical Committee 
(Licence Protocol 021/2011‐CPqGM). The concentra-
tion of IFN-γ was measured in peripheral blood mono-
nuclear cells (PBMC) culture SN by capture ELISA using 
a protocol previously described by Pereira and collabora-
tors [27]. Briefly, PBMC purified in a Ficoll-Paque PLUS 
(GE Healthcare) gradient were suspended in RPMI-1640 
medium (Sigma Aldrich) supplemented with 10  % FBS, 
10 mM HEPES (Invitrogen), pH 7.0, 2 mM l-glutamine 
(Sigma Aldrich) and 50  µg/mL gentamycin (complete 
RPMI medium). One hundred microliters of PBMC sus-
pension at 2 × 105/mL were placed per well in a 96-well 
flat-bottom microtritation plate. One hundred µL/well of 
the following solutions were added to four wells: (a) com-
plete RPMI, (b) SN of culture of COS-7 cells transfected 
with a plasmid encoding canine IL-2 (pcDNA3.1-caIL-2) 
[27] diluted 1:10 (COS-7 cells caIL-2 SN), (c) rsccaIL-12L 
at 40  ng/mL, or (d) rsccaIL-12L at 40  ng/mL in combi-
nation with COS-7 cells caIL-2 SN diluted 1:10. Then 
PBMC were cultured in a humidified atmosphere with 
5  % CO2, at 37  °C, for 48  h. After that, supernatants of 
each quadruplicate were pooled, spun down at 300×g for 
5 min to remove the cells and stored at −20 °C until use. 
The concentration of IFN-γ in the SN was determined 
by capture ELISA using specific antibodies produced 
by R&D Systems (Minneapolis, USA), according to the 
manufacturer’s instructions. A calibration curve was pre-
pared with recombinant IFN-γ (R&D Systems) follow-
ing the manufacturer’s instructions and GraphPad Prism 
v.5.0 software.
Statistical analysis
The values for IFN-γ concentration were compared by 
Repeated Measures ANOVA followed by Dunnett’s post-
test. Values of p < 0.05 were considered significant. The 
statistical analysis was performed and graphs made using 
GraphPad Prism v.5.0 software.
Results
Expression of recombinant canine IL‑12
To confirm transfer of the inserts (sccaIL-12, sccaIL-
12opt, and the segment between Tn7R and Tn7L from 
empty vector) from pFastBac1 plasmid constructs or 
pFastBac1 empty plasmid to either AcBac or AcBacΔCC 
bacmid, PCR was carried with primers flanking the bac-
mid transposition sites. Amplicons produced by PCR 
showed the expected size (data not shown), indicating 
success in obtaining the recombinant (AcBac-sccaIL-12, 
AcBacΔCC-sccaIL-12, AcBac-sccaIL-12opt, AcBacΔCC-
sccaIL-12opt) and negative control (AcBac-pFast-cont, 
and AcBacΔCC-pFast-cont) bacmids.
To determine the best conditions for recombinant 
canine IL-12 expression in insect cells, High-five cells 
were infected with each of the four recombinant baculo-
virus constructs at MOI 2, 5 and 10, or one of the nega-
tive controls at MOI 10, and culture SN were assessed by 
dot-blot analysis at 24, 48 and 72  h post-infection (pi), 
using an antibody specific for C-terminal his-tags. Taking 
into account the background signal observed when SN of 
High-five cells cultured with AcBac-pFast-cont baculo-
virus was utilized at MOI 10 (Fig. 2), cells infected with 
recombinant baculovirus constructs started producing 
recombinant canine IL-12 after 48 h pi. Interestingly, the 
largest amounts of cytokine were secreted when the High-
five cells were infected with the AcBac-sccaIL-12opt and 
AcBacΔCC-sccaIL-12opt baculovirus constructs, whose 
inserts had codons optimized for expression in Trichoplu-
sia ni, at MOI 2 72 h pi, MOI 5 48 or 72 h pi, and MOI 10 
48 or 72 h pi (Fig. 2). High-five cells also synthesized the 
recombinant protein when infected with AcBac-sccaIL-12 
and AcBacΔCC-sccaIL-12 constructs, but at a lower level 
comparing to the cells exposed to baculovirus constructs 
carrying the codon-optimized insert (AcBac-sccaIL-12opt 
and AcBacΔCC-sccaIL-12opt) (Fig.  2). High-five cells 
infected with AcBac-sccaIL-12, AcBacΔCC-sccaIL-12, 
AcBac-sccaIL-12opt, and AcBacΔCC-sccaIL-12opt bacu-
lovirus constructs at MOI 5 for 48 h were selected as the 
conditions for further studies.
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Baculovirus constructs containing sccaIL‑12opt promote 
efficient production of recombinant canine IL‑12 
by High‑five cells
To assess the efficiency of secretion of recombinant 
canine IL-12, cell culture SN and lysates of High-five 
cells infected with either AcBac-sccaIL-12, AcBacΔCC-
sccaIL-12, AcBac-sccaIL-12opt, AcBacΔCC-sccaIL-
12opt, AcBac-pFast-cont or AcBacΔCC-pFast-cont 
baculovirus constructs at MOI 5 for 48 h were evaluated 
by Western blot with anti-His C-term antibodies.
In Western blot analysis, culture SN of cells infected 
with AcBac-sccaIL-12 or AcBacΔCC-sccaIL-12 baculo-
virus construct showed a protein band with a molecular 
mass of 67  kDa (Fig.  3a, b, lanes 2), which was absent 
in the negative control SN (Fig.  3a, b, lanes 1). In addi-
tion, the culture SN of cells infected with either the 
Fig. 2 Optimization of canine IL-12 single-chain protein expression in the baculovírus-insect cell system. High-Five cells were infected with distinc-
tive baculovírus constructs using different multiplicity of infection (MOI) and time of infection (TOI). Dot-blot assay was carried out using 150 μL 
of infected cell culture supernatant proteins impregnated on nitrocellulose membrane and anti-His C-Term antibodies followed by anti-mouse 
immunoglobulin-alkaline phosphatase conjugate and substrate
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AcBac-sccaIL-12opt or the AcBacΔCC-sccaIL-12opt 
baculovirus construct showed two strong bands with 
molecular masses of 67 and 70  kDa, being these bands 
strongest when AcBacΔCC-sccaIL-12opt construct was 
used (Fig. 3a, b, lanes 3). Therefore, the amount of IL-12 
detected in the SN of cells infected with either bacu-
lovirus construct carrying the codon optimized insert 
(AcBac-sccaIL-12opt and AcBacΔCC-sccaIL-12opt) was 
higher than in the SN of cells cultured with baculovirus 
constructs carrying native canine IL-12 cDNA (AcBac-
sccaIL-12 and AcBacΔCC-sccaIL-12).
Analyzed by Western blot, lysates of cells infected 
with AcBac-sccaIL-12 or AcBacΔCC-sccaIL-12 showed 
a weak broad band of average molecular mass of 67 kDa 
and a weak band of 61 kDa, respectively,which were not 
seen -in negative control lysates. Lysates of cells infected 
with AcBac-sccaIL-12opt and AcBacΔCC-sccaIL-12opt 
baculovirus constructs displayed a strong broad band 
with an average molecular mass of 67  kDa and a weak 
band of 61  kDa (Fig.  3), which were not present in the 
negative control lysates. In addition, lysate of High-five 
cells infected with AcBac-sccaIL-12opt presented a weak 
band of 54 kDa (Fig. 3), absent in the corresponding neg-
ative control lysate.
Western blot results suggest that the AcBacΔCC-
sccaIL-12opt recombinant baculovirus construct induced 
the highest amount of secreted recombinant canine IL-12 
(rsccaIL-12L) and more than half of the total recombi-
nant protein produced was retained within the cells.
To determine the yield and biological activity, rsc-
caIL-12L was purified from the SN of High-Five cells 
infected with AcBacΔCC-sccaIL-12opt baculovirus 
construct at MOI 5 for 48  h. After purification from 
the cell SN by affinity chromatography, rsccaIL-12L 
displayed a single band with molecular weight size of 
68.5  kDa in Western blot and SDS–PAGE analysis 
(Fig.  4). Considering the amount of the recombinant 
protein purified from 50  mL of cell culture SN, it was 
estimated a yield of 6 mg of rsccaIL-12L per liter of cul-
ture. Purified rsccaIL-12L had 0.1 EU of endotoxin per 
mg of protein.
The fluorescence spectrum of rsccaIL-12L showed 
maximum peak in 338 nm (Fig.  5a), suggesting that the 
recombinant protein was properly folded. In addition, 
circular dichroism analysis revealed a spectrum with a 
maximum negative ellipticity at 210  nm, indicating that 
the target protein has a predominantly β-sheet structure 
(Fig. 5b).
Fig. 3 Detection of canine IL-12 single-chain protein produced by infected High-five cells by Western blot. High five cells were infected with the 
following baculovirus constructs AcBac-pFast-cont (lanes 1, 4), AcBac-sccaIL-12 (lanes 2, 5), AcBac-sccaIL-12opt (lanes 3, 6) (a) or AcBacΔCC-pFast-cont 
(lanes 1, 4), AcBacΔCC-sccaIL-12 (lanes 2, 5), AcBacΔCC-sccaIL-12opt (lanes 3, 6) (b), at multiplicity of infection 5 for 48 h. Proteins from supernatants 
and lysates from the same volume of cell culture were fractioned into SDS–PAGE and transferred to nitrocellulose membrane. Membrane strips 
were incubated with mouse anti-his C-Term antibodies, followed by anti-mouse immunoglobulin-alkaline phosphatase conjugate and substrate
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Recombinant canine sccaIL‑12L produced by High‑five cells 
induces IFN‑γ in homologous PBMC
The biological activity of rsccaIL-12 was evaluated by 
testing its ability to induce IFN–γ production in PBMC 
from six healthy adult dogs. Canine PBMC were cul-
tured for 48  h with:(a) complete RPMI, (b) COS-7 cells 
caIL-2 SN, (c) rsccaIL-12L, or (d) rsccaIL-12L in com-
bination with COS-7 cells caIL-2 SN. IFN-γ was meas-
ured in culture SN by capture ELISA. Canine PBMC 
have not produced IFN-γ when cultured in complete 
RPMI (mean ± SD, 1 ± 1 pg/mL) or in the presence of 
SN COS-7 containing IL-2 (1  ±  2  pg/mL). PBMC of 3 
out of 6 dogs produced IFN-γ when cultured with rsc-
caIL-12L at 20 ng/mL, however, the mean concentration 
(mean ± SD, 38 ± 40 pg/mL) observed in the SN of stim-
ulated cells was not significantly different from the SN 
of cells cultured in medium alone (Fig. 6). Nevertheless, 
when PBMC were stimulated with both rsccaIL-12L at 
20  ng/ml and SN COS-7 containing IL-2, cells of 6 out 
of 6 dogs produced significantly higher amounts of IFN-γ 
(247  ±  134  pg/mL) than cells cultured with complete 
RPMI (Fig.  6), indicating that purified rsccaIL-12L was 
biologically active.
Discussion
IL-12 has the potential to promote, alone or in combina-
tion with other immunomodulatory agents, cell-medi-
ated immune responses [9, 25–27], which are useful in 
the control of infections caused by intracellular patho-
gens, of allergic diseases mediated by antibody [28], and 
of neoplasms [26]. Aiming at optimizing conditions to 
produce tens of milligrams of canine IL-12 for future pre-
clinical trials in dogs, several parameters were evaluated 
in the present work, including different baculovirus con-
structs, and time of infection (TOI 24, 48 and 72 h) and 
multiplicity of infection (MOI 2, 5 and 10) of High-five 
insect cells.
In order to obtain a good yield of secreted mammalian 
recombinant protein in the baculovirus-insect cell sys-
tem, DNA constructs have been used with: (a) elements 
potentially capable of promoting translation or secre-
tion or (b) baculovirus vector framework knocked out of 
genes encoding proteins targeted to endoplasmic reticu-
lum. For example, to enhance translation, constructs have 
been made with: (a) AT rich nucleotide sequence before 
the initiation codon and an adenine at position +4, that 
would promote recognition of mRNA by ribosomes 
in insect cells, instead of Kozak sequence [29–31], (b) 
codons specifically optimized for the species of the used 
host [32]. To improve secretion, constructs have been 
prepared with: (a) signal peptide encoding sequences 
from proteins efficiently targeted to endoplasmic reticu-
lum of insect cells, like AcMNPV GP64 protein or honey-
bee venom melittin, instead of native signal peptide [31, 
33], or (b) a baculovirus vector from which several genes 
were deleted, for example, chitinase, cathepsin, p10, p26 
and p74 [23, 34–36], which encode proteolytic enzymes 
or proteins capable of competing for secretory machinery 
resources of the host cell.
In the current study, a recombinant baculovirus con-
struct (AcBac-sccaIL-12) was used with the classic bac-
ulovirus vector framework (AcBac) and canine native 
DNA encoding IL-12 (sccaIL-12). In addition, recombi-
nant baculovirus constructs were used with: (a) AcBac 
knockout of chitinase and cathepsin genes (AcBacΔCC) 
and sccaIL-12 insert (AcBacΔCC-sccaIL-12), (b) AcBac 
and an insert comprised of DNA encoding AcMNPV 
GP64 signal peptide and canine IL-12 mature poly-
peptides, with optimized codons for translation in T. ni 
(sccaIL-12opt) (AcBac-sccaIL-12opt) and, (c) AcBacΔCC 
Fig. 4 Analysis of purified rsccaIL-12L produced in the baculovirus-
insect cell system by SDS–PAGE and Western blot. Recombinant 
sccaIL-12L was produced by High-five cells infected with the 
AcBacΔCC-sccaIL-12opt baculovirus construct at MOI 5 for 48 h. 
Clarified and buffer-exchanged cell culture supernatant was applied 
to Ni-Sepharose affinity chromatography column and the recom-
binant protein was eluted using an imidazole linear gradient. The 
chromatographic fractions were analyzed by SDS–PAGE and Western 
blot. Polyacrylamide gel showing: molecular weight markers (lane 
1), clarified buffer-exchanged cell culture supernatant applied to the 
chromatographic column (10 μL, lane 2), flow through fraction (10 μL, 
lane 3), and sample of a chromatographic fraction containing rsc-
caIL-12 (10 μL, lane 4) (a). Nitrocellulose membrane showing purified 
sccaIL-12 incubated with normal mouse serum diluted 1:500 (lane 1) 
or mouse anti-his C-Term antibodies (lane 2), followed by anti-mouse 
immunoglobulin-alkaline phosphatase conjugate and substrate (b)
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and sccaIL-12opt (AcBacΔCC-sccaIL-12opt). Further-
more, constructs were assessed by their ability to pro-
mote IL-12 secretion in High-Five cells to determine if 
any of the changes made in basic construct design was 
advantageous.
The constructs were evaluated initially by assessing cul-
ture SN of High Five cells infected with MOI 2, 5 or 10 and 
TOI 24, 48 or 72 h, using the dot-blot assay. All baculo-
virus constructs were able to induce the secretion of both 
rsccaIL-12S and rsccaIL-12L recombinant proteins. How-
ever, AcBac-sccaIL-12opt and AcBacΔCC-sccaIL-12opt 
constructs induced the largest quantities of rsccaIL-12L- 
the latter being slightly more efficient than the former. 
These results suggest that the use of: (a) AcMNPV GP64 
signal peptide, in contrast to the native signal peptide, 
and/or (b) codons optimized for T. ni (in contrast to the 
canine native codons), and (c) a baculovirus vector devoid 
of cathepsin and chitinase genes (in contrast to the classi-
cal baculovirus vector), contributed to increased produc-
tion of secreted recombinant protein. Factors described in 
“a” and “b” had a greater impact than the one mentioned 
in “c”. Interestingly, in one experiment in which produc-
tion of secreted recombinant canine IL-12 was assessed 
by dot-blot of the supernatant of Sf-9 cells infected with 
MOI 2, 5 and 10 and TOI of 24, 48 and 72  h, the four 
baculovirus constructs were equally efficient (data not 
shown), suggesting that replacement of the native signal 
peptide for that of AcMNPV GP64, optimizing codons for 
T. ni and the use of a baculovirus vector devoid of cath-
epsin and chitinase genes have no impact on expression 
in Sf-9 cells. These results are in agreement with reports 
by several authors which show that certain changes in the 
insert and in the genome of the baculovirus vector itself 
can promote an increased yield of recombinant proteins 
and that the same baculovirus construct may promote dif-
ferent yields in different host cells, e.g., Sf9 and High-Five 
cells [37–39]. Therefore, the baculovirus-insect cell sys-
tem is not fully predictable [33].
Various methods have been used for detection 
of secreted recombinant proteins in the process of 
Fig. 5 Fluorescence and circular dichroism of rsccaIL-12L. Intrinsic fluorescence spectra of rsccaIL-12L obtained by excitation at 280 nm, and emis-
sion from 295 to 415 nm (a). Circular dichroism spectra of rsccaIL-12L, at 190–260 nm, resulting from three consecutive measurements at the speed 
of 50 nm/min (b)
Fig. 6 Assessment of IFN-γ production by peripheral blood 
mononuclear cells (PBMC) stimulated with rsccaIL-12L. PBMC from 
six adult mongrel dogs were cultured for 48 h with: complete RPMI 
1640 medium alone (medium), COS-7 cells supernatant containing 
canine IL-2 at 20 % (IL-2), purified rsccaIL-12L at 20 ng/mL (IL-12); or 
purified sccaIL-12L at 20 ng/mL combined with COS-7 cell SN-caIL-2 
(IL-2 + IL-12). IFN-γ was assessed in the PBMC supernatants by 
capture ELISA. Data represent the average of duplicates and means 
obtained from six animals. Repeated measures ANOVA: p < 0.0001, 
Dunnett´s test *p < 0.05
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optimizing production conditions in baculovirus-insect 
cell system, including ELISA [37, 39, 40], enzyme assay 
[41, 42] and Western blot analysis [23, 43, 44]—the lat-
ter being most commonly used. Western blot analysis 
is a labor-intensive method that involves several steps, 
including separation in polyacrylamide gel and transfer 
to nitrocellulose membrane, before protein detection. 
In the current study, a simpler method (dot-bot) was 
successfully used to optimize production conditions 
of a recombinant protein secreted in the culture SN of 
cells grown in serum-free medium. The best conditions 
for production of the recombinant protein were MOI 
5 and TOI 48  h. These conditions were chosen taking 
into account the difference between the signal to noise 
ratio observed in the dot-blot assay. In our laboratory, 
dot-blot analysis was also successfully used to optimize 
production of three other secreted recombinant pro-
teins in the baculovirus-insect cell system (unpublished 
data).
To determine the secretion efficiency and integrity of 
the recombinant canine IL-12 produced by High-five 
cells infected with each of the four recombinant bacu-
lovirus constructs at the best conditions, Western blot 
assays were carried out using samples of the culture SN 
and cell lysates. Taking into account the presence and 
intensity of bands with molecular masses between 67 
and 70  kDa detected by anti-His tagged antibody, the 
total production (sum of the recombinant protein in cul-
ture SN and cell lysate) and secretion of the recombinant 
canine IL-12, it can be concluded that the recombinant 
protein was obtained in progressively larger amounts by 
the constructs AcBac-sccaIL-12, AcBacΔCC-sccaIL-12, 
AcBac-sccaIL-12opt and AcBacΔCC-sccaIL-12opt. Data 
concerning detection of the recombinant protein in cul-
ture SN corroborate the findings of the dot-blot assay, 
confirming that the use of the GP64 signal peptide and 
the codons optimized for T. ni had the greatest impact 
and that the baculovirus vector framework devoid of 
cathepsin and chitinase genes impacted only modestly on 
the production of the secreted IL-12.
For unknown reasons, when the constructs AcBac-
sccaIL-12opt and AcBacΔCC-sccaIL-12opt were used, 
apparently, most of the translated protein was retained 
inside the host cells (Fig.  3). A few studies have also 
shown that sometimes, especially while using High-Five 
cells, baculovirus constructs have the potential to induce 
secretion of tens to hundreds of milligrams of recombi-
nant proteins per liter of cell culture [39, 45]. Since the 
yield of canine IL-12 observed in this study was lower 
than 10 mg/L of culture, it is improbable that the secre-
tory machinery was overwhelmed to explain the reten-
tion of most of the recombinant cytokine within the 
host cells. Many authors have also observed retention 
of secretable recombinant protein inside the cells when 
using the baculovirus-insect cell system [23, 39, 46, 47]. 
The presence of a small number of bands detected in the 
cell lysate by Western blot, being the majority of bands 
detected with molecular masses above the predicted 
mass for the mature protein (rsccaIL-12S, 58.3 kDa and 
rsccaIL-12L, 61.3  kDa), suggests that there was little, 
if any, proteolysis of the recombinant protein during 
the production process. The two bands (67 and 70 kDa) 
observed in culture SN of cells infected with AcBac-
sccaIL-12opt and AcBacΔCC-sccaIL-12opt baculovirus 
constructs probably represent glycosylated isoforms of 
rsccaIL-12L [23]. Assessment of glycosylation of rsccIL-
12L is underway.
In view of the results obtained from dot blot and West-
ern blot assays, the baculovirus construct AcBacΔCC-
sccaIL-12opt was used to infect High-Five cells at MOI 
5 and TOI 48 in order to produce recombinant canine 
IL-12 for purification and biological evaluation.
To determine the quality, samples of the purified pro-
tein were analyzed by SDS–PAGE, Western blot, fluo-
rescence emission spectrum, circular dichroism, and 
for endotoxin contamination. Evaluation carried out by 
SDS–PAGE with gel stained with Coommassie blue and 
Western blotting showed a single band with an aver-
age molecular mass of 68.5 kDa, instead of the expected 
two bands of 67 and 70 kDa, previously detected during 
analysis of culture SN. This was probably related to the 
greater amount of protein used in the previous experi-
ments making the bands appear fused. Assessment by 
the fluorescence emission spectrum and circular dichro-
ism revealed data compatible with a folded protein pre-
dominantly composed of beta sheets. These findings are 
consistent with data previously reported for human IL-12 
[48, 49]. Endotoxin was detected only in very low concen-
trations. Finally, determination of protein concentration 
carried out in samples of two independent experiments 
allowed the estimation of a yield of 6–9  mg of sccaIL-
12L per liter of insect cell culture. Therefore, taking into 
account protein purity, integrity, folding, endotoxin con-
tamination, and yield, the recombinant protein was suc-
cessfully purified.
The functional activity of the purified protein (rsccaIL-
12L) was determined by its ability to induce the synthesis 
of IFN-γ in canine PBMC. Previous studies reported the 
requirement of dual stimulation, using both IL-12 and 
IL-2, for the induction of IFN-γ secretion by canine PBMC 
[27]. In the current study, PBMC from healthy dogs were 
cultured with rsccaIL-12L alone or in combination with 
COS-7 SN containing IL-2, the latter at a concentration 
that was unable to induce IFN–γ synthesis by itself. Stimu-
lation with rsccaIL-12L alone induced IFN-γ production 
above background levels in 3 out of 6 dogs, although this 
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was not statistically significant. On the other hand, stim-
ulation with rsccaIL-12L in combination with COS-7 SN 
containing IL-2 resulted in synthesis of IFN-γ by PBMC 
from all six dogs tested, and compared with PBMC cul-
tured with COS-7 SN containing IL-2 alone or medium 
alone, this was statistically significant, thus, indicating that 
the recombinant protein produced was biologically active. 
Previously, Poot et al. [21] have produced canine IL-12 in 
the baculovirus-insect cell system and shown it is able to 
induce proliferation of equine lymphoblasts. Unfortu-
nately, these authors have not assessed the ability of canine 
IL-12 to stimulate the IFN-γ synthesis in canine PBMC 
that would allow some comparison with the current work.
In conclusion, this is the first description of a method 
for production of bioactive canine IL-12 in suitable 
amounts for pre-clinical trials. In addition, the combi-
nation of several factors (use of AcMNPV GP64 signal 
sequence, codons optimized to insect cells, and baculo-
virus knockout for chitinase and cathepsin) described 
in the current manuscript has a wide application in the 
field of recombinant protein production, useful for future 
studies on prophylactic and therapeutic interventions in 
cancer, inflammatory and infectious diseases in dogs.
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